New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 18, 2012
16:24 EDTNLSN, SWHC, GTAT, ARB, ORCL, HEB, RGROn The Fly: Closing Wrap
Stocks on Wall Street were higher, with the buying spurred on by optimism surrounding the fiscal cliff negotiations. After surging higher during the first half of the trading session, the averages moved in a narrow range through the afternoon, though held onto gains and closed right near their highs... ECONOMIC EVENTS: In the U.S., the National Association of Home Builders index of builder confidence increased to 47, as was forecast. Also, the current-account deficit in the U.S. narrowed in the third quarter to $107.5B from a $118.1B shortfall in the prior quarter. Economists expected the deficit would narrow to about $103B... COMPANY NEWS: After the bell, Oracle (ORCL) reported earnings and revenues that beat Street expectations. Shares, which had been up 1.67% during the trading session, moved up another 1.5% in after hours trading following the report... Gunmakers Smith & Wesson (SWHC) and Sturm, Ruger (RGR) continued their recent weakness as private equity firm Cerberus Capital Management's decision to put gunmaker Freedom Group up for sale added new pressure on those stocks. Shares of Smith & Wesson lost 86c, or 9.99%, to close at $7.79, while shares of Sturm, Ruger fell $3.40, or 7.73%, to close at $40.60... MAJOR MOVERS: Among the notable gainers was Arbitron (ARB), up $8.99, or 23.63%, to $47.03 after agreeing to be bought by Nielsen (NLSN) for $48 per share in cash. Shares of acquirer Nielsen also gained $1.30, or 4.39%, to $30.92. Among the noteworthy losers was GT Advanced Technologies (GTAT), which was downgraded at Raymond James and Stifel Nicolaus and saw shares fall 39c, or 11.27%, to $3.07 after issuing guidance well below consensus. Also lower was Hemispherex Biopharma (HEB), down 27.6c, or 42.86%, to 36.8c, after the FDA posted documents in advance of a review of the company's Ampligen drug, noting that the agency had concerns with the drug's efficacy and safety data... INDICES: The Dow was up 115.57, or 0.87%, to 13,350.96; the Nasdaq was up 43.93, or 1.46%, to 3,054.53; and the S&P 500 was up 16.43, or 1.15%, to 1,446.79.
News For ORCL;SWHC;RGR;ARB;NLSN;HEB;GTAT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 27, 2015
07:21 EDTSWHCSmith & Wesson March volatility elevated into O3 and outlook
Subscribe for More Information
February 25, 2015
17:07 EDTRGRSturm, Ruger reports adjusted Q4 EPS 53c, consensus 40c
Subscribe for More Information
10:12 EDTRGRHigh option volume stocks
High option volume stocks: WBAI HDS ICON NWBO RGR GFI RKT TJX RSG LC
February 20, 2015
06:51 EDTNLSNNielsen files automatic mixed securities shelf
Subscribe for More Information
February 19, 2015
11:04 EDTORCLOracle unveils new big data solutions
Subscribe for More Information
February 18, 2015
04:55 EDTORCLStocks with implied volatility movement; MO ORCL
Subscribe for More Information
February 16, 2015
17:24 EDTORCLFIS, Oracle among those exploring Monitise bid, Sky News reports
FIS (FIS) is among the U.S. companies considering a takeover bid for Monitise, the UK mobile banking software manufacturer which put itself up for sale last month, Mark Kleinman of Sky News reports. Other possible bidders include Oracle (ORCL) and IBM (IBM), Kleinman added. He pointed out that all of the takeover discussions are said to be at an early stage. Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use